Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Nov 1;52(3):387-90.
doi: 10.1097/QAI.0b013e3181b05f62.

Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients

Vicki Greengrass  1 , Barbera Lohman, Lisa Morris, Megan Plate, Pauline M Steele, Judd L Walson, Suzanne M Crowe
Affiliations

Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients

Vicki Greengrass et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Viral load (VL) is a critical marker for monitoring HIV disease progression and response to antiretroviral therapy. In resource-constrained settings, there is a need for a simple and inexpensive assay to monitor infected adults and children.

Methods: We compared versions 2 and 3 of the ExaVir Load assay, Cavidi AB (HIV RT) with the Roche, COBAS Amplicor HIV-1 Monitor assay (HIV RNA) for quantifying HIV VL.

Results: The HIV RT version 2 assay showed good sensitivity with detection in 94% of samples with HIV RNA >1000 copies per milliliter. Adult samples were tested using HIV RT version 2 (n = 35) and version 3 (n = 23) assays with plasma volumes of 1 mL (recommended), 0.5 mL and 0.25 mL in comparison with HIV RNA. The HIV RT and HIV RNA assay results were comparable when tested using different volumes. Comparison of results from pediatric samples (n = 27), tested using 1 mL and a smaller volume by HIV RT version 2 were not significantly different.

Conclusions: The HIV RT assay was comparable to the HIV RNA assay with sensitivity approaching that of HIV RNA. Smaller volumes than the recommended 1 mL can be used, improving utility of this assay for pediatric monitoring.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HIV viral load results using different plasma volumes from 35 adult HIV+ patients tested using the HIV RT assay version 2 (a) and version 3 (b). HIV RNA values are shown using +. HIV RT values using the recommended 1 ml of plasma are shown using ●, 0.5ml plasma results using ◐ and 0.25 ml plasma results using ○. Samples shown in grey are below the detection limit of the HIV RT assay and have been assigned the assay detection limit.
Figure 2
Figure 2
HIV viral load results using different plasma volumes from 27 pediatric HIV+ individuals tested using the HIV RT assay version 2. HIV RT results using the larger volume of plasma (range: 1 to 0.3ml) are shown in dark grey and the smaller volume (range: 0.15 to 0.5ml, adjusted for dilution factor) are shown in light grey, * Results from 1ml plasma tested (n=6) as the recommended sample volume.
See this image and copyright information in PMC

References

    1. Crowe S, Turnbull S, Oelrichs R, et al. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin Infect Dis. 2003;37(Suppl 1):S25–35. - PubMed
    1. Rouet F, Rouzioux C. The measurement of HIV-1 viral load in resource-limited settings: how and where? Clin Lab. 2007;53(3–4):135–148. - PubMed
    1. Fiscus SA, Cheng B, Crowe SM, et al. HIV-1 Viral Load Assays for Resource-Limited Settings. PLoS Medicine. 2006;3(10):e417. - PMC - PubMed
    1. Malmsten A, Shao XW, Sjodahl S, et al. Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J Med Virol. 2005;76(3):291–296. - PubMed
    1. Kamat A, Ravi V, Desai A, et al. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay. J Clin Virol. 2007;39(1):9–15. - PubMed

Substances